Xeris Pharmaceuticals | XERS - Action





Action Changement Date
Celltrion KRW 126B 3.06B 2026-03
Cspc Pharmaceutical CNY 3.09B 219.95M 2025-12
Divis Laboratories Ltd INR 39.54B 7.18B 2026-03
Eli Lilly USD 16.79B 2.26B 2026-06
Kangmei Pharma CNY 2.38B 73.9M 2026-03
Knight Therapeutics CAD 95.4M 2.91M 2024-03
Laboratorios Farma EUR 327.67M 2.28M 2025-06
Medical Developments International AUD 9.45M 679K 2025-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Organigram Holdings CAD 135.16M 2.45M 2026-03
Pacira USD 134.57M 15.8M 2026-06
Perrigo USD 1.06B 56.9M 2026-06
Pharma Mar EUR 49.53M 3.59M 2026-06
Qiagen NV USD 309.61M 7.72M 2026-03
Sartorius EUR 831.9M 4.8M 2026-06
Sino Biopharmaceutical CNY 1.84B 156.17M 2024-06
Supernus Pharmaceuticals USD 107.03M 3.74M 2026-06
Tilray USD 282.79M 11.9M 2025-06
Zealand Pharma A/S 10.7M 9.9M 2024-12
Zz Pientze Pharmaceu CNY 6.28B 553.86M 2026-03